Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Float Short %

1.59

Margin Of Safety %

14

Put/Call OI Ratio

0.5

EPS Next Q Diff

-0.42

EPS Last/This Y

8.49

EPS This/Next Y

0.54

Price

186.91

Target Price

203.12

Analyst Recom

2.43

Performance Q

7.1

Relative Volume

0.4

Beta

0.27

Ticker: BDX




20 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-08-15BDX195.920.920.1443925
2025-08-18BDX195.060.580.4527895
2025-08-19BDX198.10.561.8328821
2025-08-20BDX199.240.580.8729120
2025-08-21BDX196.50.580.8829389
2025-08-22BDX199.640.580.2829459
2025-08-25BDX194.660.581.0029536
2025-08-26BDX194.080.580.4229596
2025-08-27BDX195.470.580.8629707
2025-08-28BDX191.30.581.2429891
2025-08-29BDX1930.581.2529865
2025-09-02BDX188.130.581.0330140
2025-09-03BDX189.610.590.7230269
2025-09-04BDX191.410.590.3930597
2025-09-05BDX192.350.590.0330363
2025-09-08BDX191.60.620.6329696
2025-09-09BDX190.560.6225.2229708
2025-09-10BDX188.490.510.4527599
2025-09-11BDX190.60.510.3027590
2025-09-12BDX186.840.500.3027847
DateSymbolLastP/C OIP/C VolTotal OI
20 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-08-15BDX195.973.0534.314.35
2025-08-18BDX195.103.0513.214.35
2025-08-19BDX198.033.0558.214.35
2025-08-20BDX199.273.0537.214.35
2025-08-21BDX196.632.8493.614.37
2025-08-22BDX199.652.8557.914.37
2025-08-25BDX194.612.8465.314.37
2025-08-26BDX194.072.8516.214.37
2025-08-27BDX195.462.8539.214.37
2025-08-28BDX191.332.8475.814.37
2025-08-29BDX192.822.8541.614.37
2025-09-02BDX188.112.8465.914.37
2025-09-03BDX189.592.8540.214.37
2025-09-04BDX191.292.8542.914.37
2025-09-05BDX192.392.8536.314.37
2025-09-08BDX191.582.8513.514.37
2025-09-09BDX190.542.8510.814.37
2025-09-10BDX188.542.8499.914.37
2025-09-11BDX190.562.8548.414.37
2025-09-12BDX186.912.8479.914.37
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-08-15BDX-0.16-1.141.92
2025-08-18BDX-0.16-0.941.92
2025-08-19BDX-0.16-0.941.92
2025-08-20BDX-0.16-0.941.92
2025-08-21BDX-0.16-0.941.92
2025-08-22BDX-0.16-0.941.92
2025-08-25BDX-0.16-0.481.92
2025-08-26BDX-0.17-0.481.92
2025-08-27BDX-0.17-0.481.81
2025-08-28BDX-0.17-0.481.81
2025-08-29BDX-0.17-0.481.81
2025-09-02BDX-0.17-0.471.81
2025-09-03BDX-0.17-0.471.81
2025-09-04BDX-0.17-0.471.81
2025-09-05BDX-0.17-0.471.81
2025-09-08BDX-0.17-0.411.81
2025-09-09BDX-0.17-0.411.81
2025-09-10BDX-0.17-0.411.81
2025-09-11BDX-0.35-0.411.59
2025-09-12BDX-0.35-0.411.59
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS

3.68

Avg. EPS Est. Current Quarter

3.92

Avg. EPS Est. Next Quarter

3.26

Insider Transactions

-0.35

Institutional Transactions

-0.41

Beta

0.27

Average Sales Estimate Current Quarter

5905

Average Sales Estimate Next Quarter

5412

Fair Value

212.47

Quality Score

68

Growth Score

83

Sentiment Score

46

Actual DrawDown %

35

Max Drawdown 5-Year %

-40.1

Target Price

203.12

P/E

33.6

Forward P/E

12.57

PEG

5.3

P/S

2.5

P/B

2.1

P/Free Cash Flow

21

EPS

5.56

Average EPS Est. Cur. Y​

14.37

EPS Next Y. (Est.)

14.91

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

7.51

Relative Volume

0.4

Return on Equity vs Sector %

-18.6

Return on Equity vs Industry %

-2.6

EPS 1 7Days Diff

EPS 1 30Days Diff

0.19

EBIT Estimation

479.9
Becton, Dickinson and Company
Sector: Healthcare
Industry: Medical Instruments & Supplies
Employees: 70000
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation systems, and medication inventory optimization and tracking systems; hemodynamic monitoring systems; and prefillable drug delivery systems. The BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.
stock quote shares BDX – Becton, Dickinson and Company Stock Price stock today
news today BDX – Becton, Dickinson and Company stock forecast ,stock prediction 2023 2024 2025
marketwatch BDX – Becton, Dickinson and Company yahoo finance google finance
stock history BDX – Becton, Dickinson and Company invest stock market
stock prices BDX premarket after hours
ticker BDX fair value insiders trading